Endoscopic submucosal dissection for IgG4-related gastric disease presenting with submucosal elevation: a case report

doi:10.3877/cma.j.issn.2095-2015.2025.06.020

Abstract

Abstract:

Immunoglobulin G4 (IgG4)-related disease is a rare, systemic autoimmune disorder that can affect multiple organs. Gastric involvement is uncommon and often presents with non-specific clinical and radiological features, posing a diagnostic challenge and frequently leading to misdiagnosis as gastric neoplasms or lymphoma. In this report, we present a case of IgG4-related gastric disease diagnosed and managed with endoscopic submucosal dissection, resulting in complete lesion resection.

Key words: IgG4-related disease, IgG4-related gastric disease, Autoimmune disease, Endoscopic submucosal dissection

Jing Dai, Min Lin, Yingchun Hu. Endoscopic submucosal dissection for IgG4-related gastric disease presenting with submucosal elevation: a case report[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2025, 15(06): 676-680.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2025.06.020

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2025/V15/I06/676

Figures/Tables 4

References 26

[1]	Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192.
[2]	张盼盼, 赵继志, 王木, 等. IgG 4相关性疾病346例临床特征分析[J]. 中华内科杂志, 2017, 56(9): 644-649.
[3]	Stone JH, Zen Y, Deshpande V. IgG4-related disease[J]. New Engl J Med, 2012, 366: 539-551.
[4]	Löhr JM, Vujasinovic M, Rosendahl J, et al. IgG4-related diseases of the digestive tract[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(3): 185-197.
[5]	Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic(RCD) criteria for IgG4-RD[J]. Mod Rheumatol, 2021, 31(3): 529-533.
[6]	Zhang L, Smyrk TC. Autoimmune pancreatitis and IgG4-related systemic diseases[J]. Int J Clin Exp Pathol, 2010, 3(5): 491-504.
[7]	Wallace ZS, Zhang Y, Perugino CA, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts[J]. Ann Rheumat Dis, 2019, 78(3): 406-412.
[8]	Bohlok A, El Khoury M, Tulelli B, et al. A rare presentation of IgG4 related disease as a gastric antral lesion: Case report and review of the literature[J]. Int J Surg Case Rep, 2018, 51: 244-247.
[9]	Sawada H, Czech T, Silangcruz K, et al. Clinicopathological characteristics of gastric IgG4-related disease: systematic scoping review[J]. J Gastroenterol Hepatol, 2022, 37(10): 1865-1872.
[10]	Skorus U, Kenig J, Mastalerz K. IgG4-related disease manifesting as an isolated gastric lesion-a literature review[J]. Pol J Surg, 2018, 90(4): 41-45.
[11]	Seo HS, Jung YJ, Park CH, et al. IgG4-related disease in the stomach which was confused with gastrointestinal stromal tumor(GIST): two case reports and review of the literature[J]. J Gastric Cancer, 2018, 18(1): 99.
[12]	Khan S, Zhu LP, Jiang K, et al. Immunoglobulin G4-Related Disease Manifesting as Isolated, Typical, and Nontypical Gastroesophageal Lesion: A Research of Literature Review[J]. Digestion, 2020, 101(5): 506-21.
[13]	Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease[J]. Clin Exp Immunol, 2015, 181(2): 191-206.
[14]	Perugino CA, AlSalem SB, Mattoo H, et al. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease[J]. J Allergy Clin Immunol, 2019, 143(2): 736-745. e6.
[15]	Maehara T, Mattoo H, Mahajan VS, et al. The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching in vivo[J]. Life Sci Alliance, 2018, 1(1): e201800050.
[16]	Terao C, Ota M, Iwasaki T, et al. IgG4-related disease in the Japanese population: a genome-wide association study[J]. Lancet Rheumatol, 2019, 1(1): e14-e22.
[17]	Ishikawa Y, Terao C. Genetic analysis of IgG4-related disease[J]. Mod Rheumatol, 2020, 30(1): 17-23.
[18]	Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?[J]. J Cell Mol Med, 2005, 9(3): 741-744.
[19]	Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis[J]. Gut, 2005, 54(5): 703-709.
[20]	Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis[J]. New Engl J Med, 2009, 361(22): 2135-2142.
[21]	Culver EL, Smit WL, Evans C, et al. No evidence to support a role for Helicobacter pylori infection and plasminogen binding protein in autoimmune pancreatitis and IgG4-related disease in a UK cohort[J]. Pancreatology, 2017, 17(3): 395-402.
[22]	Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699.
[23]	Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial[J]. Ann Rheumat Dis, 2015, 74(6): 1171-1177.
[24]	Ebbo M, Grados A, Samson M, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients[J]. PloS One, 2017, 12(9): e0183844.
[25]	Omar D, Chen Y, Cong Y, et al. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis[J]. Rheumatology, 2020, 59(4): 718-726.
[26]	Yoshifuji H, Umehara H. Glucocorticoids in the treatment of IgG4-related disease-Prospects for new international treatment guidelines[J]. Mod Rheumatol, 2023, 33(2): 252-257.

Please choose a citation manager

Content to export